Thursday - September 16, 2021
Launch of Bayer Science Collaboration Explorer:

Bayer launches transparency register for scientific collaborations with external partners

Open access database makes new contract-based scientific collaborations with universities, public research institutions and individuals publicly available in Germany

Leverkusen, September 16, 2021 – Bayer AG is the first company in the future DAX-40-index to introduce a transparency register. The Bayer Science Collaboration Explorer is aimed at improving long-term public confidence in science and research. The database ( provides access to new contract-based scientific collaborations with universities, public research institutions and individuals in Germany.

“Solving humanity’s major challenges requires trusted scientific innovations. For that, we need transparency,” says Bayer AG CEO Werner Baumann. “Today we are presenting the Bayer Science Collaboration Explorer, a leading initiative setting standards for corporate transparency and community engagement.”

Dr. Monika Lessl, Head of Corporate R&D and Social Innovation at Bayer, added: “With the Bayer Science Collaboration Explorer, Bayer and our external partners want to create more transparency regarding our scientific collaborations. We see the register as an important element towards promoting dialogue between society, business, and research on the topic of new scientific discoveries.” The transparency register will initially launch in Germany before being introduced in further countries.

Specifically, the following core details will be published for each contract: Name and country of the institution/person, collaboration type (e.g., research contract), subject of collaboration (e.g., oncology, digital farming), funding committed, effective date, participating Bayer division.

Announcement during Bayer Transparency Day – Inside Science

At 2:00 p.m. on September 16, 2021, Werner Baumann, CEO of Bayer AG, will introduce the Bayer Science Collaboration Explorer during Bayer’s virtual “Transparency Day – Inside Science” event. Following its publication, experts from science, business, media, and civil society will discuss the following theme: “Collaborations between companies and research institutions: Transparency as a key to societal trust?” A recording will be made available on the event website ( after the event.

You can find out more about the Bayer Science Collaboration Explorer here (

About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Download Center
file(s) collected

View Download Center


Dr. Dieter Hilla

Phone +49 214 30-58992